Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a man or woman between 18 and 65 years old
- You have been diagnosed with schizophrenia or schizoaffective disorder based on standard medical guidelines (DSM 5.0)
- You are currently taking at least one antipsychotic medication
- You still experience hearing voices despite having your medication dose adjusted and optimised for at least 6 weeks, with symptoms above a certain measured level
- Your medication dose has remained stable for at least 6 weeks before starting the trial treatment
- You are able to understand and communicate in French
- If you are a legally protected adult, your legal guardian or appointed representative has agreed to your participation
- You are willing and able to attend all scheduled visits as required by the trial
- You are covered by French Social Security, or have equivalent European healthcare cover
- You are willing to give your informed written consent to take part
Who may not be able to join:
- You are currently pregnant
- You have a condition or implanted device that makes brain stimulation (rTMS) unsafe, such as a history of epilepsy, a pacemaker, a cardiac defibrillator, certain implants or prostheses, metal clips in the brain, fluid drainage devices in the brain, or metal fragments in the eyes
- You are already taking part in, or planning to join, another medical research study
- You are unable to complete all the required follow-up visits and appointments in the trial
- You have a known brain abnormality, or one is found during a brain MRI scan
- You have a condition or implanted device that makes having an MRI scan unsafe, such as certain metal dental prostheses, a pacemaker, a cardiac defibrillator, certain implants or prostheses, metal clips in the brain, fluid drainage devices in the brain, metal fragments in the eyes, or severe claustrophobia (fear of enclosed spaces)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sonia Dollfus, University Caen Normandie
Phone: 02.31.06.50.18
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the number of times a patient is assessed as a responder
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.